This Week’s Biotech, Energy and Mining Stocks added to InvestorIdeas Directories

This Week’s Biotech, Energy and Mining Stocks added to InvestorIdeas Directories

Point Roberts, WA, Delta BC – March 3, 2017 – Investorideas.com, a global news source and investor resource covering actively traded sectors announces this week’s additions to its investor membership, including global stock directories in biotech, energy and mining

Investorideas.com tracks companies in high profile trading sectors and makes ongoing additions to its stock directories for each sector.  Listing for the stock directories include companies on the TSX, OTC, NYSE, NASDAQ and global stock exchanges.

The latest biotech companies include Kalytera Therapeutics, Inc. (TSX: KALY.V) which is working with advancing CBD therapies and thus crosses into our cannabis stocks list.

The newest energy company is Molori Energy Inc. (TSX: MOL.V; OTCQB: MOLOF), an oil and gas production company with current operations in the Texas Panhandle.

Both new mining companies are Canadian listed and active in lithium as well as other metals and are also now listed on our renewable energy stock list in the lithium section. Power Americas Minerals Corp. (TSX:PAM.V) (formerly Victory Ventures) has operations in South America and is included in our North American stocks doing business in Latin America – Chile, Peru, Mexico and Colombia list.

Read this release in full at http://www.investorideas.com/news/2017/biotech/03031Stocks.asp

New Biotech Companies Added:

Kalytera Therapeutics, Inc. (TSX: KALY.V) is pioneering the development of a next generation of cannabinoid therapeutics. Through its proven leadership, drug development expertise, and intellectual property portfolio, Kalytera seeks to establish a leading position in the development of novel cannabinoid medicines for a range of important unmet medical needs. Kalytera is focused first on developing a new class of proprietary cannabidiol (“CBD”) therapeutics. CBD is a remarkable compound that has shown activity against a number of pharmacological targets. However, there are limitations associated with natural CBD, including its poor oral bioavailability and short half-life. Kalytera is developing innovative CBD formulations and prodrugs in an effort to overcome these limitations, and to target specific disease sites within the body. Kalytera intends to file composition of matter and method of use patents covering its novel inventions, with the goal of limiting future competition.

New Energy Companies Added:

Molori Energy Inc. (TSX: MOL.V; (OTCQB: MOLOF)  is an oil and gas production company with current operations in the Texas Panhandle. Founded in 2011, the experienced management team is aggressively acquiring select properties which provide immediate cash flow and development opportunities, now and in the years ahead. Molori is seizing the opportunity, in the current oil & gas environment, to assemble oil and gas production in nearby and politically safe jurisdictions. Molori is pursuing a business plan, whereby the Company either purchases producing oil and gas assets at highly attractive rates, or in some cases simply takes on existing assets by way of purchasing or assuming default notes from small regional lenders and institutions.

New Mining Companies Added:

One World Minerals Inc. (CSE:OWM) is a successful exploration and development Company with geologists having experience over the last 30 years in gold, silver, base metals and lithium.

Power Americas Minerals Corp. (TSX:PAM.V) (formerly Victory Ventures) acquisition strategy focuses on acquiring affordable, cost effective and highly regarded mineral properties in areas with proven geological potential. These areas include historical and currently producing mines with existing infrastructure. This strategy includes acquiring 100% interests in mineral properties, with no payment terms or work program commitments that would threaten a junior mining company's financial stability. The Company believes it can create maximum shareholder value efficiently and cost effectively implementing this acquisition strategy. The Company believes that the demand profile for Cobalt, Lithium, Copper, and other essential power related materials will be fundamentally led by the growing adaptation of electric vehicles, renewable energy and increased production of super alloys. With a focus on identifying and developing ethically sourced materials within the Americas, the Company intends to address the growing demand for energy metals that are being driven by innovation and the introduction of new technologies. Power Americas Minerals Corp. is a Canadian-based junior mining exploration company focused on the procurement, exploration and development of cobalt, lithium, copper and other energy metals in North and South America.

Investorideas.com global stock directories are part of the membership program on the site, accessed either by login and password or available in PDF format.  The directories include stocks trading on the TSX, OTC, NASDAQ, NYSE and other recognized global stock exchanges, giving retail investors a wide variety of stocks to review. http://www.investorideas.com/membership/

The directories are not meant as recommendations but as a research tool to discover opportunities and trading ideas in a particular sector.

About Investorideas.com - News that Inspires Big Ideas

Investorideas.com is a meeting place for global investors, featuring news, stock directories, video, company profiles, interviews and more in leading sectors.  

Sectors we cover include tech, bitcoin and blockchain, biotech, mining, energy, renewable energy, water stocks, marijuana and hemp stocks, food and beverage (including organic and LOHAS, wine), defense and security (including biometrics), Latin America, sports, entertainment, luxury brands and gaming.

The Investorideas.com content portfolio goes beyond the www.investorideas.com site to include 12 blogs on Blogger.com, 7 Artificial Intelligence (AI) websites on the Grid and the Waternewswire.com, all featuring Investorideas.com news and content.

Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas

Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas

Investor Ideas Directories for global investors:

From water stocks to gold and mining stocks, renewable energy, nanotech, defense, technology, biotech and more – use our stock directories and access them online 24/7 with login as a member to find your next big idea!

http://www.investorideas.com/membership/

Services for Publicly traded companies: http://www.investorideas.com/Investors/Services.asp

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution,social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894.  Global investors must adhere to regulations of each country.

Contact Investorideas.com

800-665-0411

SilverCrest (TSXV: $SIL.V) Reports First Drill Results from Babicanora Vein; Multiple Intercepts Greater Than 1,000 gpt AgEq*

VANCOUVER - March 2, 2017 (Investorideas.com Newswire) SilverCrest Metals Inc. (TSXV: $SIL.V), is pleased to announce its first drill hole results for the Babicanora Vein within the Las Chispas Property (the "Property") located in Sonora, Mexico . As part of the Company's Phase II Exploration Program, underground drilling at the Babicanora Vein is testing the historic silver-gold mine (see attached Photos and Figures). In the 1800s, the Babicanora historic mine (the "Mine") was considered the largest precious metal producer in the region.

The Mine began operations around 1790 by Spanish operators, with intermittent production up to 1935. By the late 1800s, historic public records show that production for the Mine was approximately 80 million ounces of silver and an unknown amount of gold. As with the three other veins currently being explored by the Company (Las Chispas, William Tell and Varela veins), the Babicanora Vein had not been previously drilled.

N. Eric Fier , CPG, P.Eng, President & CEO remarked, "We expected the area drilled to be mostly mined out and are very pleased to discover that much of the mineralization in this area is intact. The initial drill hole results at the Babicanora Vein suggests high-grade mineralization and a continuous, well-defined mineralized vein and structure that averages over four metres in true thickness. We have been able to trace the Babicanora Vein, on surface and underground, for over one kilometre within an altered and mineralized trend that is over 2.5 kilometres long and 1 kilometre wide. Underground access to this vein is via a 230-metre long 4 by 4 metre horizontal adit (see attached Photo), which was driven by a French company during the 1860s. We are drilling the Babicanora Vein from the face of this adit, and are encountering high grade drill intercepts within 8 to 33 metres of the adit."

The most significant result for this release is a true thickness intercept in Hole UB17-05 of 6.1 metres grading 4.84 grams per tonne ("gpt") gold and 383 gpt silver, or 746 gpt silver equivalent ("AgEq"; based on a ratio of 75 (Ag):1 (Au) and 100% metallurgical recovery) including 0.6 metres grading 2,907 gpt AgEq. Also noteworthy is a 5.0 metre intercept grading a weighted average 3.91 gpt gold and 182.5 gpt silver, or 476 gpt AgEq in Hole LC17-04. The following table summarizes the most significant drill assay results (uncut, undiluted) for the Babicanora Vein only;

Notes: all numbers are rounded.
*AgEq based on 75 (Ag):1 (Au) and 100% metallurgical recovery.

All assays were completed by ALS Chemex in Hermosillo, Mexico , and North Vancouver, BC.

All drill holes have intercepted epithermal quartz veining, stockwork veinlets, breccia and/or shears trending NW to SE, dipping 60 to 70 degrees SW. From historic records, the Mine was developed, in the early 1900s, 200 to 300 feet below the adit elevation but only partially mined due to water issues. The first four holes were drilled below the adit elevation (1152 masl). Hole UB17-01 was prematurely halted due to a lost bit. Hole UB17-01a was drilled adjacent to lost hole. Hole UB17-02 intersected footwall stockwork but did not intercept its intended target due to the hole azimuth being near-parallel to the dip of the vein. Hole UB17-03 intercepted a one-metre wide underground working and is included in the average width and grade based on hangingwall and footwall assays. Holes UB17-04 and UB17-05 were drilled above the tunnel elevation where historic mining occurred. Drilling for holes 4 and 5 intercepted intact vein, stockwork and mineralized fill material in historic workings. Some intercepts experienced less than 50% core recovery due to the presence of historic workings, fill material and fractured ground. All holes bottomed in low grade silver-gold mineralization.

At least six historic underground mining chutes remain intact on the adit level and are filled with undetermined amounts of mineralized material. For mapping, sampling and drill site access purposes, the Company has removed, sampled and stockpiled approximately 800 tonnes of this mineralized material (see attached Photos of chute and stockpile).

Drill results also suggest low grade precious metal mineralization in the hangingwall of the Babicanora Vein. As part of Phase II drilling, the near surface projection of this mineralization will be explored in Q2, 2017 to test a potential near-surface bulk tonnage target. Historically, Babicanora was considered a gold-dominant producer near the surface transitioning to a silver-dominant producer at depth.

To date, the Company has completed approximately fifty percent of the Las Chispas Phase II Exploration Program having drilled 20 core holes totalling about 4,500 metres. Fourteen holes have been drilled in the Las Chispas and William Tell veins for expansion and resource delineation with six holes drilled in the Babicanora Vein. Based on positive Phase I and Phase II drilling results to date, the Company's intention is to mobilize additional drill rigs to Las Chispas in late Q1 2017, including a man-portable drill for Las Chispas and William Tell underground drilling.

The Qualified Person under National Instrument 43-101 Standards of Disclosure for Mineral Projects for this news release is N. Eric Fier , CPG, P.Eng, and President and CEO for SilverCrest, who has reviewed and approved its contents.

Read this release in full at http://www.investorideas.com/CO/SILV/news/2017/03021Reports.asp

ABOUT SilverCrest Metals INC.

SilverCrest is a Canadian precious metals exploration company headquartered in Vancouver, BC, that is focused on new discoveries, value-added acquisitions and targeting production in Mexico’s historic precious metal districts. The Company is led by a proven management team in all aspects of the precious metal mining sector, including the pioneering of a responsible “phased approach” business model taking projects through discovery, finance, on time and on budget construction, and production with subsequent increased value to shareholders.  

FORWARD-LOOKING STATEMENTS

This news release contains "forward-looking statements" within the meaning of Canadian securities legislation. Such forward looking statements concern the net proceeds from the Offering and the intended use of proceeds. Such forward looking statements or information are based on a number of assumptions, which may prove to be incorrect. Assumptions have been made regarding, among other things: conditions in general economic and financial markets; timing and amount of capital expenditures; and effects of regulation by governmental agencies. The actual results could differ materially from those anticipated in these forward looking statements as a result of the risk factors including: the availability of funds; the timing and content of work programs; results of exploration activities of mineral properties; the interpretation of drilling results and other geological data; and general market and industry conditions. Forward-looking statements are based on the expectations and opinions of the Company's management on the date the statements are made. The assumptions used in the preparation of such statements, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date the statements were made. The Company undertakes no obligation to update or revise any forward-looking statements included in this news release if these beliefs, estimates and opinions or other circumstances should change, except as otherwise required by applicable law

N. Eric Fier, CPG, P.Eng.
CEO and President
SilverCrest Metals Inc.

Neither TSX Venture Exchange nor its Regulation Services Provider (as defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE: SilverCrest Metals Inc.

Contact:

SilverCrest Metals Inc.

Fred Cooper, Investor Relations

Telephone: +1 (604) 694-1730
Fax: +1 (604) 694-1761
Toll Free: 1-866-691-1730 (Canada & USA)

Email: info@silvercrestmetals.com
Website: www.silvercrestmetals.com

Visit this Company: http://www.silvercrestmetals.com

More info on SIL.V at Investorideas.com: http://www.investorideas.com/CO/SILV/

Sign up for the free investor news and stock alerts:

http://www.investorideas.com/Resources/Newsletter.asp

This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp. Disclosure:Investorideas.com is compensated by SilverCrest Metals Inc for annual news publishing effective January 2017.

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.

This Week’s Biotech, Nanotech and Mining Stocks also added to Investor Directories

This Week’s Biotech, Nanotech and Mining Stocks also added to Investor Directories

Point Roberts, WA, Delta BC – February 24, 2017 – Investorideas.com, a global news source and investor resource covering actively traded sectors announces this week’s additions to its investor membership, including global stock directories in biotech, nanotech and mining

Investorideas.com tracks companies in high profile trading sectors and makes ongoing additions to its stock directories for each sector.  Listing for the stock directories include companies on the TSX, OTC, NYSE, NASDAQ and global stock exchanges.

The latest Biotech companies include those working with cannabinoids along with companies working in pain management, oncology, weight management, cystic fibrosis, OTC Medications, treatment for neurological diseases such as Alzheimer’s and ALS, kidney and vascular disease and new oral drug delivery systems.

Nanotech company additions coincide with a fully updated Nanotechnology stock list and include a cross-over company into the biotech sector, a company that provides nanotech tools and an investment company that has formed a joint partnership with Vietnam-based Nanotech firm.

See Nanotech stocks directory preview at http://www.investorideas.com/Nanotechnology/

New mining companies are both operating in Canada (Ontario and Quebec) and mining for copper and gold respectively.

Read this release in full at http://www.investorideas.com/news/2017/main/02241Stocks.asp

New Biotech Companies Added:

Arena Pharmaceuticals, Inc. (NasdaqGS:ARNA) a biopharmaceutical company, discovers, develops, and commercializes novel drugs that target G protein-coupled receptors. The company offers BELVIQ, a drug used to treat chronic weight management in adults. One of the products under development is APD371, an agonist of the cannabinoid receptor 2 that is in Phase I single-ascending dose trial for the treatment of pain. The company also manufactures drug products under a manufacturing services agreement for Siegfried AG

Cara Therapeutics, Inc. (NasdaqGM:CARA) is a clinical-stage biotechnology company focused on developing and commercializing new chemical entities designed to alleviate pain and pruritus by selectively targeting peripheral kappa opioid receptors. Cara is developing a novel and proprietary class of product candidates that target the body's peripheral nervous system and have demonstrated initial efficacy in patients with moderate-to-severe pain without inducing many of the undesirable side effects typically associated with currently available pain therapeutics.

Cerulean Pharma Inc. (NasdaqGM:CERU) The Cerulean team is committed to improving treatment for people living with cancer. We apply our Dynamic Tumor Targeting™ Platform to create a portfolio of nanoparticle-drug conjugates (NDCs) designed to selectively attack tumor cells, reduce toxicity by sparing the body's normal cells, and enable therapeutic combinations. Our first platform-generated NDC clinical candidate, CRLX101, is in clinical trials in combination with other cancer treatments, all of which aim to unlock the power of combination therapy. Our second platform-generated NDC clinical candidate, CRLX301, is in a Phase 1/2a clinical trial.

Corbus Pharmaceuticals Holdings, Inc. (NasdaqGM:CRBP) is a clinical stage pharmaceutical company focused on the development and commercialization of novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases. The Company's lead product candidate, JBT- 101, is a novel synthetic oral endocannabinoid-mimetic drug designed to resolve chronic inflammation, and fibrotic processes. In November 2016, Corbus reported positive topline data results from a Phase 2 study in diffuse cutaneous systemic sclerosis, showing clear signal of clinical benefit with JBT-101. The Company recently completed a Phase 2 study of JBT-101 for the treatment of cystic fibrosis with topline data expected to be announced before the end of the first quarter of 2017. Additionally, JBT-101 is being evaluated in a Phase 2, 12-month open label extension study in systemic sclerosis, a Phase 2 study in skin-predominant dermatomyositis, with a 12-month open label extension study in dermatomyositis and another Phase 2 study in systemic lupus erythematosus planned to commence in the first quarter of 2017.

CTT Pharmaceutical Holdings Inc. (OTCQB:CTTH) principal asset is a unique and novel patented drug delivery technology, an orally administered, fast dissolving thin film (the "Wafer"). This technology platform will target both the human and veterinarian (pet) markets for treatment of many diseases including pain management. The Oral Thin Film (Wafer) formulation is protected by several Canadian and US Patents. CTT's oral fast dissolving drug delivery systems will consist of edible thin films (wafers) that dissolve without water, within a few seconds after placement in the mouth. The majority of drugs administered using our drug delivery system mirror injections in that they have the ability to enter the bloodstream quickly, are convenient and discrete, and can be administered anywhere. A faster absorption rate is achieved because the mouth contains a very thin mucosa and is extremely vascular. There is no bitter taste, no smoke inhalation as is the case with cannabis, and less degradation of medication (by bypassing the stomach) and most importantly lower dosage units are required given the efficacy of absorption. Patient compliance is improved, especially with those who have a fear of choking and/or are pediatric, geriatric or incapacitated patients who have difficulty swallowing. Most fast dissolving systems on the market today deliver anti-inflammatories, antihistamines and cough and breathing related medications. CTT believes that its Wafer technology will be one of the first to gain use in major markets such as pain management.

Innovus Pharmaceuticals, Inc. (OTC: INNV) is an emerging over-the-counter (“OTC”) consumer goods and specialty pharmaceutical company engaged in the commercialization, licensing and development of safe and effective non-prescription medicine and consumer care products to improve men’s and women’s health and vitality and respiratory diseases. Innovus Pharma delivers innovative and uniquely presented and packaged health solutions through its (a) OTC medicines and consumer and health products, which we market directly, (b) commercial partners to primary care physicians, urologists, gynecologists and therapists, and (c) directly to consumers through our on-line channels, retailers and wholesalers. The Company is dedicated to being a leader in developing and marketing new OTC and branded Abbreviated New Drug Application (“ANDA”) products. The Company is actively pursuing opportunities where existing prescription drugs have recently, or are expected to, change from prescription (or Rx) to OTC.

Mateon Therapeutics, Inc. (NasdaqCM: MATN) is a biopharmaceutical company seeking to realize the full potential of vascular targeted therapy (VTT) in oncology. VTT includes vascular disrupting agents (VDAs) such as the investigational drugs that Mateon is developing, and anti-angiogenic agents (AAs), a number of which are FDA-approved and widely used in cancer treatment. These two approaches have distinct yet complementary mechanisms of action. At Mateon, we believe that we can significantly improve cancer therapy by employing these two complementary approaches simultaneously. When utilized this way, VDAs obstruct existing blood vessels in the tumor leading to significant central tumor cell death while AAs prevent the formation of new tumor blood vessels. Mateon is committed to leveraging our intellectual property and the product development expertise of our highly skilled management team to enable VTT to realize its true potential and to bring much-needed new therapies to cancer patients worldwide.

Mirna Therapeutics, Inc. (NasdaqGM: MIRN) is a clinical stage biopharmaceutical company developing a pipeline of microRNA-based oncology therapeutics and is the first to bring a synthetic microRNA mimic into clinical development for the treatment of cancer. Mirna's lead product candidate, MRX34, a mimic of naturally occurring microRNA-34 (miR-34), is being studied in a Phase 1 clinical trial which has included patients with primary liver cancer, advanced solid tumors and hematological malignancies. miR-34 is one of the most widely published microRNAs and is considered a key regulator of multiple oncogenes across key oncogenic pathways, with the capacity to regulate more than 30 different oncogenes and repress immune checkpoint signaling molecules, including PD-L1. The potential capacity to simultaneously affect multiple pathways and processes that are critical to cancer cell viability may make mimics of tumor suppressor microRNAs an important new class of anti-cancer agents. Mirna plans to develop MRX34 as a monotherapy and in combination with other therapies. The Company was founded in 2007 and is located in Austin, Texas.

Nivalis Therapeutics, Inc. (NasdaqGM: NVLS) is a pharmaceutical company that has historically been focused on the discovery and development of product candidates for patients with cystic fibrosis, or CF. Our GSNOR inhibitors selectively target an enzyme known as S-nitrosoglutathione reductase, which we refer to as GSNOR. GSNOR regulates levels of an endogenous protein known as S-nitrosoglutathione, or GSNO.  Depleted levels of GSNO have been associated with CF, asthma, inflammatory bowel diseases and certain cardiovascular diseases. However, in light of recent disappointing results of a Phase 2 clinical trial of our lead product candidate, cavosonstat, in CF, we determined to not pursue the development of this compound in CF and to wind down our research and development activities as we shift our strategic emphasis to investigating and evaluating strategic alternatives.

Oramed Pharmaceuticals Inc. (NasdaqCM: ORMP) is a platform technology pioneer in the field of oral delivery solutions for drugs currently delivered via injection. Established in 2006, Oramed's Protein Oral Delivery (PODTM) technology is based on over 30 years of research by scientists at Jerusalem's Hadassah Medical Center. Oramed is seeking to revolutionize the treatment of diabetes through its proprietary flagship product, an orally ingestible insulin capsule (ORMD-0801).  The Company completed multiple Phase II clinical trials of ORMD-0801 under an Investigational New Drug application with the U.S. Food and Drug Administration. In addition, Oramed is developing an oral GLP-1 analog capsule (ORMD-0901).

ProMIS Neurosciences Inc. (TSX: PMN.TO) The mission of ProMIS Neurosciences is to discover and develop precision medicine therapeutics for effective treatment of neurodegenerative diseases, in particular Alzheimer's disease and ALS. ProMIS Neurosciences' proprietary target discovery engine is based on the use of two, complementary techniques. The Company applies its thermodynamic, computational discovery platform—ProMIS™ and Collective Coordinates — to predict novel targets known as Disease Specific Epitopes (DSEs) on the molecular surface of misfolded proteins. Using this unique "precision medicine" approach, ProMIS Neurosciences is developing novel antibody therapeutics and specific companion diagnostics for Alzheimer's disease and ALS. The company has also developed two proprietary technologies to specifically identify very low levels of misfolded proteins in a biological sample. In addition, ProMIS Neurosciences owns a portfolio of therapeutic and diagnostic patents relating to misfolded SOD1 in ALS, and currently has a preclinical monoclonal antibody therapeutic against this target.

Proteon Therapeutics Inc. (NasdaqGM: PRTO) is committed to improving the health of patients with kidney and vascular diseases through the development of novel, first-in-class therapeutics. Proteon's lead product candidate, vonapanitase, is an investigational drug intended to improve hemodialysis vascular access outcomes. Proteon is currently enrolling patients in a Phase 3 clinical trial, PATENCY-2. Proteon is also evaluating vonapanitase in Phase 1 clinical trials in patients with peripheral artery disease (PAD).

New Nanotech Companies Added:

Cerulean Pharma Inc. (NasdaqGM:CERU) The Cerulean team is committed to improving treatment for people living with cancer. We apply our Dynamic Tumor Targeting™ Platform to create a portfolio of nanoparticle-drug conjugates (NDCs) designed to selectively attack tumor cells, reduce toxicity by sparing the body's normal cells, and enable therapeutic combinations. Our first platform-generated NDC clinical candidate, CRLX101, is in clinical trials in combination with other cancer treatments, all of which aim to unlock the power of combination therapy. Our second platform-generated NDC clinical candidate, CRLX301, is in a Phase 1/2a clinical trial.

Oxford Instruments PLC (LSE:OXIG.L) is a provider of technology tools and systems for industry and research. The Company operates through three segments: Nanotechnology Tools, Industrial Products and Service. The Nanotechnology Tools segment offers technology products serving research customers in both the public and private sectors. The Industrial Products segment contains a group of businesses supplying technology products and components manufactured in medium volume for industrial customers. The Service segment contains the Company's service, rental and refurbished asset sales business. Its NanoAnalysis business delivers solutions and services that enable materials characterization and sample manipulation at the nano scale. Its products are used on electron microscopes and ion-beam systems in academic institutions and industrial applications, including semi-conductors, renewable energy, mining, metallurgy and forensics. Its products include AZtecOne and X-Max Extreme detector, among others.

PHI Group Inc. (OTC:PHIL) primarily focuses on acquisitions as a principal and invests in energy, natural resources and special situations that may substantially enhance shareholder value.  In addition, the Company also provides merger and acquisition advisory services through its wholly owned subsidiary PHI Capital Holdings, Inc. and earns revenues in forms of cash and equity for services rendered. Nanotech – January 2017: signed an agreement with Nhat Hai New Technology JSC, a Vietnam-based company specializing in applied research and nanotechnologies (http://www.nanotechnology.com.vn), to form a joint venture company in the United States to apply the latter’s nanotechnologies for the production of various nano products.

New Mining Companies Added:

Hadley Mining Inc. (CSE:HM) is a Toronto based mineral company which owns 25% of the Pigeon River nickel-copper claim in Ontario.

Secova Metals Corp (TSX:SEK.V; OTC:SEKZF; Frankfurt: N4UN.F) is a Canadian gold exploration company focused on building a strong asset base through exploration of undervalued gold projects in Canada. Management has demonstrated expertise in advancing gold exploration projects into acquisition targets, most notably in the province of Quebec. Secova has the exclusive right and option to acquire from Tres-Or Resources Inc. ("Tres-Or"), an undivided 65% right, title and interest in the contiguous Duvay and Chenier Gold Projects. Secova can earn up to 90% of the property (an additional 25% ownership) by funding a pre-feasibility study after the initial exploration expenditures to bring the property towards production. The Company has a total contiguous land package of 174 claims covering over 7,766 hectares (17,458 acres) of land. Duvay/Chenier is located in the Abitibi gold belt, one of Quebec's premier mining jurisdictions. The Company has plans to advance the development of Duvay/Chenier as well as seek other avenues of growth through acquisition and mergers. The Company also has 100% ownership of the Eagle River project which is adjacent to and on-trend to several gold projects in the Windfall Lake district of Urban Barry in Quebec. The Company wholly owns the Cobalt Bay property which is 1,996 hectares and just 102kms north of its Eagle River project in Quebec.

Investorideas.com global stock directories are part of the membership program on the site, accessed either by login and password or available in PDF format.  The directories include stocks trading on the TSX, OTC, NASDAQ, NYSE and other recognized global stock exchanges, giving retail investors a wide variety of stocks to review. http://www.investorideas.com/membership/

The directories are not meant as recommendations but as a research tool to discover opportunities and trading ideas in a particular sector.

About Investorideas.com - News that Inspires Big Ideas

Investorideas.com is a meeting place for global investors, featuring news, stock directories, video, company profiles, interviews and more in leading sectors.  

Sectors we cover include tech, bitcoin and blockchain, biotech, mining, energy, renewable energy, water stocks, marijuana and hemp stocks, food and beverage (including organic and LOHAS, wine), defense and security (including biometrics), Latin America, sports, entertainment, luxury brands and gaming.

The Investorideas.com content portfolio goes beyond the www.investorideas.com site to include 12 blogs on Blogger.com, 7 Artificial Intelligence (AI) websites on the Grid and the Waternewswire.com, all featuring Investorideas.com news and content.

Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas

Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas

Investor Ideas Directories for global investors:

From water stocks to gold and mining stocks, renewable energy, nanotech, defense, technology, biotech and more – use our stock directories and access them online 24/7 with login as a member to find your next big idea!

http://www.investorideas.com/membership/

Services for Publicly traded companies: http://www.investorideas.com/Investors/Services.asp

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution,social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894.  Global investors must adhere to regulations of each country.

Contact Investorideas.com

800-665-0411

#TSX #Mining News: Secova Metals (TSXV: $SEK) Acquires #Cobalt Property in Quebec

Vancouver, British Columbia - February 22, 2017 (Newsfile Corp.) (Investorideas.com Newswire) Secova Metals Corp. ("Secova" or the "Company") (TSXV: SEK) (FSE: N4UN) (OTC: SEKZF) is very pleased to announce that the Company has acquired 1095252 B.C. Ltd., a private B.C. Company which sole asset is the Cobalt Bay Property ("Cobalt Bay") that consists of 36 claims or approximately 1,996 contiguous hectares in Daine Township, Quebec.
The Cobalt Bay project is located 102 km north of Secova's Eagle River Project in the Windfall Lake area of Quebec and 209 km north northeast of its Duvay/Chenier project near Amos making this project easily accessible year-round from the Company's existing projects. Historic work on the property has shown that past results have been very promising, including drilling results from 1957 when the New Jersey Zinc Company returned 0.068% cobalt over 4.5 meters, including 1.5 meters of 0.17% cobalt. Secova will use its expertise in the area to develop a systematic exploration plan to determine the extent of the potential cobalt mineralization.
"The Cobalt Bay property is an opportunistic and strategic investment that is consistent with management's goals of enhancing the value of the company for our shareholders," stated Brad Kitchen, C.E.O. and Chairman of Secova Metals Corp. "The Company will use its expertise in assessing historic projects and developing an exploration plan that can effectively and efficiently define a potential resource. There is a huge demand for cobalt and the supply chain dynamics of sourcing non-conflict supply is growing rapidly fuelled by the expected surge in the production of electric vehicles. Value creation for our shareholders is our goal and we will be driving towards potentially discovering an economically minable deposit be it in gold at Duvay/Chenier & Eagle River or cobalt at the Cobalt Bay property."
The acquisition is an arms-length transaction in which the Company will issue 6.0 million common shares by way of a share exchange agreement. In connection with the transaction, the Company will issue a cash finder's fee of $52,500 payable to Anglosphere International Enterprises Limited.
Secova announced yesterday the completion of a $2.5 million private placement. A portion of the proceeds raised will be allocated for exploration on the Cobalt Bay Property.
The issuance of the acquisition and the finder's fee of common shares are subject to TSX Venture Exchange approval.
About Secova Metals Corp.
Secova Metals Corp. is a Canadian gold exploration company focused on building a strong asset base through exploration of undervalued gold projects in Canada. Management has demonstrated expertise in advancing gold exploration projects into acquisition targets, most notably in the province of Quebec. Secova has the exclusive right and option to acquire from Tres-Or Resources Inc. ("Tres-Or"), an undivided 65% right, title and interest in the contiguous Duvay and Chenier Gold Projects. Secova can earn up to 90% of the property (an additional 25% ownership) by funding a pre-feasibility study after the initial exploration expenditures to bring the property towards production. The Company has a total contiguous land package of 174 claims covering over 7,766 hectares (17,458 acres) of land. Duvay/Chenier is located in the Abitibi gold belt, one of Quebec's premier mining jurisdictions. The Company has plans to advance the development of Duvay/Chenier as well as seek other avenues of growth through acquisition and mergers. The Company also has 100% ownership of the Eagle River project which is adjacent to and on-trend to several gold projects in the Windfall Lake district of Urban Barry in Quebec. The Company wholly owns the Cobalt Bay property which is 1,996 hectares and just 102kms north of its Eagle River project in Quebec. Secova Metals trades on the TSX Venture under the symbol SEK, in the United States under the symbol SEKZF and on the Frankfurt Exchange as 4NUN.
For more information on Secova Metals Corp. please contact Morgan Good, Secova's President, at morgan.good@secovametals.com and Tel: +1 604-715-4751 or visit the website at www.secovametals.com for past news releases, media interviews and opinion-editorial pieces by CEO and Chairman Brad Kitchen.
On Behalf of the Board of Directors,
SECOVA METALS CORP.
"Brad Kitchen"
CEO and Chairman
Tel: +1 604-506-7555
info@secovametals.com
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
This press release contains "forward-looking information" that is based on the Company's current expectations, estimates, forecasts and projections. This forward-looking information includes, among other things, statements with respect to the Company's exploration and development plans. The words "will", "anticipated", "plans" or other similar words and phrases are intended to identify forward-looking information. Forward-looking information is subject to known and unknown risks, uncertainties and other factors that may cause the Company's actual results, level of activity, performance or achievements to be materially different from those expressed or implied by such forward-looking information.

More Info:

This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.

Gold Mining Stocks - Gold Mining Stocks Directory, Gold Stocks News, Research and Resources Gold-MiningStocks.com - investing ideas in gold stocks Like Gold Stocks? View our Gold / Mining Stocks Directory http://www.investorideas.com/Gold_Stocks/Stocks_List.asp

#TSX Mining News: Galileo Exploration (TSXV: $GXL) Signs Majuba Hill Property Agreement for #Copper #Silver and #Gold Potential

Vancouver, British Columbia - February 22, 2017 (Newsfile Corp.) (Investorideas.com Newswire) Galileo Exploration Ltd. (TSXV: GXL) (the "Company") is pleased to announce the signing of a Mining Lease and Option to Purchase Agreement (the "Lease") covering a 100% interest in the Majuba Hill Project (the "Property"); an advanced stage copper/silver/gold porphyry. The Property is four (4) square miles in size and is located approximately twelve miles northwest of Rye Patch Gold's Florida Canyon Mine and thirty miles northwest of Coeur Mining's Rochester Mine. Both of these mines are long lived open pit, heap leach operations producing both gold and silver. Majuba Hill is easily accessed via twenty two miles of well-maintained dirt roads from U.S. Interstate 80, in Pershing County, North Central Nevada.
Previous exploration has outlined a new and untested copper stock work/disseminated mineralized zone over a width of 500 metres and is inferred along a 700 metre plus south-south-west strike. The target outlined by anomalous copper/silver soil geochemistry, and a strong IP chargeability anomaly lies at the base of Majuba Hill under mild topography. Copper oxide mineralization extends from surface to 150 metres and sulphide mineralization has been intersected to depths of 700 metres on the property.
The Majuba Hill Mine produced 2.8 million lbs of oxide copper grading from four to twelve percent (4 to12%) copper during the period 1907 through 1947 from the top of the porphyry system.
Historically a total of 50 drill holes have tested the project and 24 holes totaling 8800 metres are reported to have intersected long intervals of copper grading 0.10% to 0.49%. This drill hole data is historic and is not 43-101-compliant, however, the work was conducted by reputable mining-exploration companies and is believed to be reliable. Recent drilling in nine diamond drill holes from 2011 - 2015 intercepted copper/silver/gold mineralization from 50 to 222 metres grading from 0.15% to 0.49% copper, 10 - 63 g/t silver, and gold values up to 0.15 g/t. The strongest mineralization was found in hole MMX24 intersecting 117 metres grading 0.43% copper and 12 g/t silver within a 222 metre section grading 0.27% copper and 10 g/t silver.
Gary Nordin, P Geo BC is the Qualified Person of Galileo Exploration Ltd. and has reviewed all exploration data and visited in the project for two days in April 2015.
Galileo's president and CEO Ron Rieder comments - "Majuba is an exciting project to mark our re-entry into the Nevada exploration scene. With four previous drill holes indicating an increase in copper grade to the south of the historic mine workings and the coincident large untested IP chargeability anomaly helping to vector in on a rather large undrilled copper, silver and gold target, we should be able to hit the ground running. We are in the process of planning the next phases of exploration and I look forward to communicating our plans in the coming weeks. In addition to Majuba we have selected several gold exploration targets that are also being pursued for acquisition, principally located in Nevada."
The 20 year Lease has the following terms to maintain the purchase option (the "Option"):

• Cash payments (in USD): of $20,000 upon execution and receipt of TSX Venture Exchange ("TSXV") approval; $25,000 on the first anniversary; $37,500 on the 2nd anniversary; $50,000 on the 3rd anniversary; $62,500 on the fourth and subsequent anniversaries; and
• Share payments (common shares of GXL): the first payment of $20,000 is due upon TSXV approval; $25,000 on the first anniversary; $37,500 on the 2nd anniversary; $50,000 on the 3rd anniversary; $62,500 on the fourth and subsequent anniversaries. Each Share Payment shall be equivalent of the cash payment in Shares at an exchange rate of CDN$1 = USD$0.90 and a Share price based on the 30trading day volume weighted average price ("VWAP") on the TSX-V immediately prior to the Payment Date; and
• Work commitments: $100,000 in year one and $350,000 in year two.

The Option to acquire the 100% interest in the Property may be exercised at any time upon payment of US two million dollars (US$2,000,000) with all prior cash payments but no share payments being credited towards the Option Exercise price.
The Owner shall be entitled to a production royalty (the "Royalty") based on the Net Smelter Returns from the production and sale of Minerals from the Property. The Royalty percentage rate for Precious Metals shall be three percent (3%) of the Net Smelter Returns. The Royalty percentage rate for metals other than Precious Metals shall be one percent (1%) of the Net Smelter Returns. The Royalty percentage rate for all other Minerals, including geothermal resources, shall be three percent (3%) of the gross revenues from the sale of such other Minerals. Lessee shall have the right at any time to purchase up to two-thirds (2/3) of the Precious Metals Royalty representing two percent (2%) of the Net Smelter Returns (thereby reducing the Precious Metals Royalty to one percent (1%) of the Net Smelter Returns. The purchase price shall be US One Million Five Hundred Thousand Dollars (US$1,500,000) for each increment representing one percent (1%) of the Net Smelter Returns.
The transactions contemplated herein are subject to approval of the TSXV.
For further information on the Company please contact Ron Rieder at rrieder@galileoexplorationltd.com, or at 604‑727‑4653.
Cautionary Note Regarding Forward-Looking Statements
Some of the statements contained in this release are forward-looking statements within the meaning of Canadian securities laws, such as statements that relate to the timing and completion of the proposed acquisition of the Majuba Hill Property, anticipated future prospects and exploration of the Property, and other statements relating to the Property. Since forward-looking statements are not statements of historical fact and address future events, conditions and expectations, forward-looking statements by their nature inherently involve unknown risks, uncertainties, assumptions and other factors well beyond the Company's ability to control or predict. Actual events, results and developments may differ materially from those contemplated by such forward-looking statements. Material factors that could cause actual events to differ materially from those described in such forwarding-looking statements include risks related to the timing of, and ability to obtain, required regulatory approvals for the Property acquisition, risks as to the future development of the Property, the uncertainty of exploration results and general economic and regulatory changes. As a result, the Company cannot guarantee that the Option to acquire Property will be exercised on the terms and within the time disclosed herein or at all. These forward-looking statements represent the Company's views as of the date of this release. There can be no assurance that forward-looking statements will prove to be accurate, as actual events and future events could differ materially from those anticipated in such statements. Readers should not place undue reliance on any forward-looking statements.
ON BEHALF OF GALILEO EXPLORATION LTD.
"Ronald A. Rieder"
Ronald A. Rieder
President/CEO
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this News Release. This news release has been prepared by management and no regulatory authority has approved or disapproved the information contained herein.

More Info:

This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.



Gold Mining Stocks - Gold Mining Stocks Directory, Gold Stocks News, Research and Resources Gold-MiningStocks.com - investing ideas in gold stocks Like Gold Stocks? View our Gold / Mining Stocks Directory http://www.investorideas.com/Gold_Stocks/Stocks_List.asp